|
Volumn 13, Issue 1, 2002, Pages 44-46
|
Hemoccult should no longer be used for the screening of colorectal cancer
|
Author keywords
Colorectal cancer; Faecal occult blood; Screening
|
Indexed keywords
APC PROTEIN;
CATALASE;
DNA;
GUAIAC;
PEROXIDASE;
PROTEIN P53;
ARTICLE;
CANCER CONTROL;
CANCER GROWTH;
CANCER MORTALITY;
CANCER SCREENING;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL STUDY;
COLONOSCOPY;
COLORECTAL CANCER;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC ACCURACY;
FECES ANALYSIS;
GENETIC ANALYSIS;
HUMAN;
LABORATORY DIAGNOSIS;
MAJOR CLINICAL STUDY;
MATHEMATICAL MODEL;
OCCULT BLOOD TEST;
ONCOGENE K RAS;
OXIDATION;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
SIGMOIDOSCOPY;
COLORECTAL NEOPLASMS;
ENDOSCOPY;
FEMALE;
HUMANS;
MALE;
MASS SCREENING;
OCCULT BLOOD;
PREDICTIVE VALUE OF TESTS;
RANDOMIZED CONTROLLED TRIALS;
SENSITIVITY AND SPECIFICITY;
|
EID: 0036228703
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf071 Document Type: Article |
Times cited : (8)
|
References (27)
|